Trial intelligence / Profile preview

EFB0027 (Met DR) PK and Glucose Effects in Type 2 Diabetes

NCT01804842Phase 2Completed

Sponsor
Elcelyx Therapeutics
Start
Dec 2012
Primary completion
Apr 2013
01

Overview

A Phase 2 trial of metformin delayed release in type 2 diabetes mellitus (T2DM), sponsored by Elcelyx Therapeutics. Started Dec 2012; status: completed.

02

Drugs

metformin delayed release
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01804842.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01804842.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call